People · Operator

William Spier

Named in public records as an officer, director or promoter · active 2009–2011 · Other, Biotechnology

2
Companies
2
Filings
$15.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Empire Resources Inc /New/OtherSeries A$12.0M$181.6M2011
Celnyx, Inc.BiotechnologySeed$3.0M$133.2M2009
Operator network

William Spier at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Douglas G. Kass · 1 companies · 1 sharedDouglas G. KassHarvey Wrubel · 1 companies · 1 sharedHarvey WrubelJack Bendheim · 1 companies · 1 sharedJack BendheimL. Rick Milner · 1 companies · 1 sharedL. Rick MilnerMorris J. Smith · 1 companies · 1 sharedMorris J. SmithNathan G. Mazurek · 1 companies · 1 sharedNathan G. MazurekNathan Kahn · 1 companies · 1 sharedNathan KahnPeter G. Howard · 1 companies · 1 sharedPeter G. HowardSandra Kahn · 1 companies · 1 sharedSandra KahnSteve Gorlin · 11 companies · 1 sharedSteve GorlinParker H. Petit · 5 companies · 1 sharedParker H. PetitDr. Kwang Kook Kim · 1 companies · 1 sharedDr. Kwang Kook KimDr. Woo-Chul Moon · 1 companies · 1 sharedDr. Woo-Chul MoonThomas R. Becnel · 1 companies · 1 sharedThomas R. BecnelEmpire Resources Inc /New/ · $12.0M raisedEmpire Resources Inc …Celnyx, Inc. · $3.0M raisedCelnyx, Inc.William SpierWS
William Spier Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside William Spier on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Steve Gorlin111
Parker H. Petit15
Peter G. Howard11
Nathan Kahn11
L. Rick Milner11
Jack Bendheim11
Douglas G. Kass11
Morris J. Smith11
Nathan G. Mazurek11
Harvey Wrubel11
Sandra Kahn11
Dr. Woo-Chul Moon11
Thomas R. Becnel11
Dr. Kwang Kook Kim11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.